| Original language | English (US) |
|---|---|
| Pages (from-to) | 275-277.e1 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 133 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2014 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps. / Hulse, Kathryn E.; Chaung, Katrina; Seshadri, Sudarshan et al.
In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 1, 01.2014, p. 275-277.e1.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps
AU - Hulse, Kathryn E.
AU - Chaung, Katrina
AU - Seshadri, Sudarshan
AU - Suh, Lydia
AU - Norton, James E.
AU - Carter, Roderick G.
AU - Kern, Robert C.
AU - Conley, David B.
AU - Chandra, Rakesh K.
AU - Tan, Bruce K.
AU - Peters, Anju T.
AU - Grammer, Leslie C.
AU - Harris, Kathleen E.
AU - Torgerson, Troy R.
AU - Kato, Atsushi
AU - Schleimer, Robert P.
N1 - Funding Information: Disclosure of potential conflict of interest: R. P. Schleimer has consultant arrangements with Interesect ENT, GlaxoSmithKline, Allakos, and Aurasense. L. C. Grammer has received grants and travel support for meetings or other purposes from the National Institutes of Health (NIH) ; has received grants from the Bazley Foundation ; has consultant arrangements with Atellas Pharmaceuticals; is employed by Northwestern University and the Northwestern Medical Faculty Foundation; has grants/grants pending with the NIH , the Food Allergy Network , and S&C Electric ; has received payment for lectures, including service on speakers' bureaus, from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and receives royalties from Lippincott , UpToDate , BMJ , and Elsevier . B. K. Tan has received grants from the NIH and the Triological Society/American College of Surgeons ; has consultant arrangements with Acclarent, Inc, and has received travel/accommodations/meeting expenses from the Foundation for Innovation, Education, and Research in Otorhinolaryngology. T. R. Torgerson has consultant arrangements with Baxter Biosciences and BD Biosciences; has grants/grants pending with Baxter Biosciences and CSL Behring ; has received payment for lectures, including service on speakers' bureaus, from Baxter Biosciences; receives royalties from New England Biolabs ; and receives payment for the development of educational presentations from Baxter Biosciences. K. E. Harris has received grants from the NIH/National Heart, Lung and Blood Institute (grant no. R37L068546 and grant no. R01HL078860 ), the NIH/National Institute for Allergy and Infectious Disease (grant no. T32A1083216 ), and the Ernest S. Bazley Trust . A. T. Peters has received payment for lectures, including service on speakers' bureaus, from Baxter. A. Kato has received a grant from the NIH (grant no. R21HL113913 ). The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was funded by National Institutes of Health grants R37 HL068546 , R01 HL078860 , R01 AI072570 , and T32 AI083216 and the Ernest S. Bazley Trust .
PY - 2014/1
Y1 - 2014/1
UR - http://www.scopus.com/inward/record.url?scp=84891738269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891738269&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2013.08.015
DO - 10.1016/j.jaci.2013.08.015
M3 - Article
C2 - 24084073
AN - SCOPUS:84891738269
VL - 133
SP - 275-277.e1
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 1
ER -